Fingolimod Completed Phase 3 Trials for Relapsing Multiple Sclerosis (RMS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01199861Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
NCT01127750Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients